Ajanta Pharma
Ajanta Pharma Limited, headquartered in India, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of a diverse range of formulations. Founded in 1973, the company has established a strong presence in various operational regions, including Asia, Africa, and the Middle East.
Ajanta Pharma is renowned for its focus on therapeutic areas such as ophthalmology, dermatology, and pain management, offering unique products that cater to specific medical needs. With a commitment to quality and innovation, the company has achieved significant milestones, including numerous approvals from regulatory authorities worldwide.
Recognised for its robust market position, Ajanta Pharma continues to expand its global footprint, driven by a dedication to enhancing patient care through effective and affordable healthcare solutions.
-8 vs industry average
Ajanta Pharma’s score of 30 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Ajanta Pharma?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Ajanta Pharma's reported carbon emissions
In 2025, Ajanta Pharma reported total emissions of approximately 63,000,000 kg CO2e, comprising 6,392,000 kg CO2e from Scope 1, 43,598,470 kg CO2e from Scope 2, and 10,790,000 kg CO2e from Scope 3. This data reflects a commitment to transparency in emissions reporting, although specific reduction targets or initiatives have not been disclosed. In 2024, the company recorded total emissions of approximately 63,900,000 kg CO2e, with Scope 1 emissions at 6,390,000 kg CO2e, Scope 2 at 40,008,000 kg CO2e, and a minimal Scope 3 contribution of 2,000 kg CO2e. The emissions for 2023 were approximately 56,000,000 kg CO2e, with Scope 1 at 4,368,550 kg CO2e and Scope 2 at 51,813,330 kg CO2e, indicating a focus on managing direct and indirect emissions. Ajanta Pharma has not set specific science-based targets or climate pledges, and there are no documented reduction initiatives at this time. The company’s emissions data is not cascaded from any parent organization, ensuring that the reported figures are solely reflective of Ajanta Pharma's operations.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Ajanta Pharma’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Ajanta Pharma yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Ajanta Pharma
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project